Dr. Liu found that scoparone improves liver inflammation and autophagy by inhibiting the PI3K/AKT/mTOR pathway in mice with non-alcoholic steatohepatitis [56]. Here, AKT1 is linked to metabolic dysfunction-associated steatohepatitis.